As of May 27
| -0.02 / -0.29%|
The 3 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 20.00 and a low estimate of 14.00. The median estimate represents a +117.08% increase from the last price of 6.91.
The current consensus among 3 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.